my bad on the quarterly date. I got the information from Yahoo confused with actual company announcements. My bad. I look forward to them announcing a date which should occur in the not to distant future.
The stock won't "spike" at all. This is a biotech, doing research and development.
R&D, research and development in a manufacturing company is an expense, oftentimes capitalized and written off as an expense over time.
CYTK is testing a couple of wonderful drugs, one an orphan, so to speak, and another with very wide application.
Any income here is simply incidental. The thing we find out during these reports is how much cas and equivalents they have left to continue functioning until results are in on tests and somebody comes up wth a huge chunk of cash to partner, or merge, or buy out the drug or certain rights or the entire company.
That's why we're here....because we think thay have the 'goods' and we'll make a bunch of dough based on effectiveness, not quarterly income.